Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Troxerutin is a semi-synthetic flavonoid derived from rutin, and it is widely used in Europe and Asia for the treatment of chronic venous insufficiency (CVI), varicose veins, and related conditions such as phlebitis (inflammation of the veins). The scientific rationale for its use is based on its pharmacological properties: troxerutin has demonstrated anti-inflammatory, antioxidant, and vasoprotective effects in both animal and human studies. Several clinical trials and reviews have shown that troxerutin can reduce symptoms such as pain, swelling, and heaviness in patients with venous disorders, including superficial forms of phlebitis. Its mechanism of action involves strengthening capillary walls, reducing vascular permeability, and inhibiting platelet aggregation and leukocyte adhesion, which are important in the development and progression of phlebitis.

While high-quality, large-scale randomized controlled trials specifically for phlebitis are limited, there is moderate evidence from smaller studies and broader research on venous inflammation to support its use. Regulatory agencies in some countries have approved troxerutin for venous and microcirculatory disorders, reflecting a level of clinical acceptance. Thus, the use of troxerutin for phlebitis is supported by a combination of mechanistic research, clinical studies, and medical guidelines, though the evidence is not as robust as for some other vascular conditions.

More about Troxerutin
More about Phlebitis

Other ingredients used for Phlebitis

Other health conditions supported by Troxerutin

Products containing Troxerutin